Lasex

Quick links to important sections

Lasex

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lasex

Property Description
Active ingredient Furosemide
Form Tablet, Solution for injection
Pharmacological class Loop Diuretic (High-ceiling)
General Purpose Relief of excessive fluid accumulation
Origin Synthetic sulfonamide-derivative

What Type of Medicine is Lasex (Furosemide)?

Lasex is a trade name for the pharmaceutical drug Furosemide, whose active ingredient is a potent diuretic. The active component, Furosemide, is a single-ingredient product classified as a Loop Diuretic. Chemically, Furosemide is a synthetic compound that is identified as a sulfonamide-derivative. Its classification as a "high-ceiling" diuretic reflects its capacity to promote rapid and significant salt and water excretion, distinguishing it from less potent diuretic classes. Lasex is typically designated as a prescription-only medicine (Rx), reflecting the necessity of professional oversight due to its significant physiological impact.


What Forms Does Lasex Come In and What is its General Purpose?

Lasex is manufactured for patient use primarily as an oral tablet and as a sterile solution for injection, accommodating administration via the oral, intravenous (IV), or intramuscular (IM) routes. The central, non-clinical purpose of Furosemide is to induce substantial diuresis, or increased urine output. This function is achieved by directly blocking the reabsorption of sodium and chloride salts in the kidney tubules. By inhibiting the kidney's ability to reclaim these salts, Furosemide ensures that large volumes of water are flushed out of the body. This potent action is fundamentally utilized to rapidly alleviate conditions characterized by excessive fluid accumulation in the body.

Regulatory References

  1. WHO Model Lists of Essential Medicines

What side effects are possible with Lasex?

Possible Side Effects and Safety Information: Lasix (Furosemide)

Lasix is a potent loop diuretic that can cause a loss of water and electrolytes. Close medical monitoring is essential during treatment, especially to check electrolyte levels (potassium, sodium, magnesium, and calcium) and kidney function.

Common and Less Severe Side Effects

The most frequently reported side effects are related to fluid and electrolyte changes or dehydration. These can include:

  • Electrolyte Imbalances: Low potassium (hypokalemia), low sodium (hyponatremia), or low magnesium.
  • Gastrointestinal: Nausea, vomiting, or diarrhea.
  • Central Nervous System: Dizziness, lightheadedness, headache, and blurred vision. Patients should rise slowly from a sitting or lying position to minimize the risk of lightheadedness or fainting (orthostatic hypotension).
  • Other: Increased urination, dry mouth, and thirst. The medication can also increase sensitivity to sunlight (photosensitivity).

Serious Side Effects and Warnings

Contact a healthcare provider immediately if you experience signs of a serious reaction, including:

System Serious Symptoms
Allergic/Skin Hives, severe rash, swelling of the face/throat, difficulty breathing (anaphylaxis).
Ototoxicity Hearing loss (can be permanent), or persistent ringing in the ears (tinnitus). This risk is higher with rapid administration, high doses, or existing kidney problems.
Dehydration/Fluid Imbalance Extreme thirst, profound weakness, muscle cramps, confusion, or a significant decrease in urination.
Liver/Pancreas Yellowing of the eyes or skin (jaundice), or severe upper stomach pain radiating to the back (pancreatitis).

Contraindications and Interactions

Lasix is generally contraindicated in patients with anuria (inability to urinate), hepatic coma, or known hypersensitivity to furosemide. Use with caution in patients with severe kidney disease, liver impairment, diabetes, or gout.

Significant Drug Interactions can occur with certain antibiotics (like aminoglycosides, increasing the risk of hearing damage) and nonsteroidal anti-inflammatory drugs (NSAIDs), which may reduce the diuretic's effectiveness. Always inform your doctor about all medications and supplements you are taking.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents strictly define the profile of furosemide (Lasex) overdose by the exaggeration of its potent diuretic effects. Any suspicion of overdosage requires immediate medical attention, as specified in the prescribing information.

Documented Clinical Profile

Overdose is characterized primarily by profound diuresis and severe blood volume reduction (hypovolaemia), leading to hypotension (low blood pressure) and syncope (fainting). Critically, this results in severe electrolyte imbalances, including Hypokalaemia and Hypochloraemia, which may cause systemic distress. Potential life-threatening outcomes documented in regulatory labels include circulatory collapse (shock) and acute renal failure.

Required Emergency Actions

The label explicitly states that immediate medical attention is required for overdose. If signs of severe volume depletion or circulatory collapse occur, contacting emergency services immediately is mandated. No specific antidote is known for furosemide. Management is strictly symptomatic and supportive, focusing on the replacement of excessive fluid and electrolyte losses. Intensive monitoring of vital signs, blood pressure, and serum electrolytes is required in a hospital setting due to the severity of these physiological changes. Elderly patients are noted to be particularly susceptible to circulatory collapse and vascular thrombosis as complications of severe dehydration.

Therapeutic Uses of Lasex

What Lasex Treats: Main Uses and Benefits

Lasex (Furosemide) is commonly used to help with symptoms related to systemic imbalance due to excessive fluid accumulation, applied across domains where additional symptomatic support is needed. The medication is relevant for easing fluid retention (edema) associated with Congestive Heart Failure (CHF), Liver Cirrhosis, and Renal Diseases, and may be part of symptomatic management for high blood pressure.

The medication addresses symptom clusters that may become intense or disruptive, such as visible swelling in the limbs, abdominal distention (ascites), and shortness of breath caused by fluid congestion in the lungs. It is applied in clinical settings that involve acute or unstable symptom patterns, and relevant in situations requiring continued assistance with fluid balance. Lasex provides support that helps ease the overall symptom burden and assists with maintaining functional stability when symptoms interfere with routine activities.

“This supportive therapy is relevant for easing symptoms related to physical discomfort and conditions marked by increased physiological stress.”

Quick Fact: Relief for Fluid Overload Symptoms Furosemide is generally considered relevant for easing symptoms in conditions marked by increased physiological stress due to noticeable fluid retention, and is often used when short-term symptomatic assistance is needed.

Regulatory References

  1. NIH DailyMed Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Lasex (Furosemide)?

Official regulatory documents define strict eligibility criteria for using Furosemide, focusing on absolute contraindications and mandatory precautions based on physiological status. The medication is approved for use in adults and pediatric patients diagnosed with edema.

Absolute Restrictions (Contraindications)

Furosemide must not be used in populations with:

  • Anuria (inability to pass urine).
  • Known hypersensitivity to Furosemide or sulfonamide-derived drugs.
  • Hypovolemia, Dehydration, or severe electrolyte imbalances (Hypokalaemia or Hyponatraemia).
  • Hepatic Coma or pre-comatose states.

Restricted and Conditional Use

Use is restricted or requires special caution in several populations:

  • Severe Progressive Renal Disease: The drug should be discontinued if increasing azotemia and low urine output occur.
  • Hepatic Cirrhosis with Ascites: Therapy is best initiated in a hospital setting.
  • Geriatric Patients: Dosing requires caution due to the increased risk of dehydration and decreased organ function.
  • Pregnancy and Lactation: Use during pregnancy is conditional upon benefit outweighing risk; the drug is contraindicated in breastfeeding women according to some labels, as it may suppress lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes officially documented interaction patterns for Lasex (Furosemide) based on governmental regulatory information.

Furosemide's interaction profile is categorized by its potential for Pharmacodynamic Potentiation of Toxicity, Exposure Modification, and Antagonism of Diuretic Effects.

Documented Interaction Patterns

Interaction Type Interacting Agent Official Regulatory Description
Formal Contraindication Ethacrynic Acid Contraindicated due to risk of potentiation of ototoxicity (hearing damage).
Pharmacokinetic Alteration Lithium Furosemide reduces the renal clearance of Lithium, leading to increased serum Lithium levels and risk of toxicity.
Pharmacodynamic Risk Aminoglycoside Antibiotics Increased risk of ototoxicity when co-administered.
Pharmacodynamic Risk ACE Inhibitors / ARBs Increased risk of severe hypotension and renal function deterioration.
Antagonism NSAIDs (e.g., Indomethacin) May reduce Furosemide's diuretic effect and increase the risk of nephrotoxicity.
Electrolyte Risk Corticosteroids, Licorice Increased risk of hypokalemia (low potassium).
Timing Constraint Sucralfate Must be administered at least two hours apart from oral Furosemide due to reduced absorption.

Population-Specific Notes

Co-treatment with Risperidone in elderly patients with dementia is associated with a higher incidence of mortality according to regulatory documentation. The drug’s ototoxicity may also be potentiated in patients with Hypoproteinemia.

Mechanism of Action

How Lasex Works

Lasex (Furosemide) exerts its effect through a specific mechanism localized entirely within the renal system. Its action is initiated by the molecule acting as an inhibitor of the Sodium-Potassium-2-Chloride Cotransporter 2 ( NKCC2) protein. This transporter is the primary molecular target, situated on the apical membrane of epithelial cells in the Thick Ascending Limb of the Loop of Henle.

The targeted inhibition prevents the reabsorption of Na^+, K^+, and Cl^- ions, thereby disrupting the renal countercurrent multiplier system. This disruption dismantles the osmotic gradient necessary for reclaiming water in the distal nephron segments. The sequential mechanism results in a substantial and rapid increase in the volume of salt and water expelled via the urine, leading to a reduction in extracellular fluid volume.

Efficacy is constrained by physiological factors, including the body's compensatory responses and the drug's access to its target. Reduced delivery to the tubule or adaptation in the distal segments can limit the net fluid effect.

Dosage and Administration Information

Lasex, containing Furosemide, is administered via oral (tablet or solution), intravenous (IV), or intramuscular (IM) routes; a specialized subcutaneous (SC) on-body infusion is also available for specific uses. Parenteral administration is generally reserved for rapid effects or when the oral route is impractical.

Standard Dosing and Frequency

The initial oral dose for adults with edema typically ranges from 20 mg to 80 mg, administered once or divided twice daily. The dose may be increased by 20 mg to 40 mg increments, given no sooner than 6 to 8 hours after the preceding oral dose to achieve the desired response. In cases of resistant edema, certain guidelines allow daily titration up to 600 mg (US) or 1500 mg (EU). For IV/IM use, the initial dose is 20 mg to 40 mg and must be injected slowly over 1 to 2 minutes. Subsequent IV doses are to be given no sooner than 2 hours later.

Timing and Population Adjustments

Oral administration is generally scheduled in the morning, and it is common practice to avoid taking the medicine late in the day (e.g., after 4 PM). The tablets may be taken with or without food. Importantly, Furosemide is typically not taken within 2 hours of sucralfate to prevent interference with absorption. For older adults, a lower initial dose is standard, requiring cautious and gradual titration. Pediatric dosing is calculated based on body weight, starting at 1 mg/kg. If a dose is missed, it is generally skipped if it is late in the day or near the time of the next scheduled dose, and a double dose is not taken.

Recent Clinical Evidence

Research evidence / Overview of studies for Lasex (Furosemide)


Evidence for Fluid Retention Associated with Heart Failure

Research that has explored Furosemide in the context of fluid accumulation associated with heart failure includes both short-term randomized controlled trials (RCTs) and long-term observational studies. These studies were conducted during periods of increased symptom activity in adults and older adults with different types of heart failure. Researchers examined outcomes related to systemic or functional imbalance, such as the measurement of change in urine output (diuresis), weight change, and changes in symptoms of congestion.

Short-term trials reported measurements of rapid and significant diuresis (increased urine output) following administration, with findings describing patterns observed in the studies that show decreased fluid markers observed in patients who received the medicine. For patients experiencing acute fluid overload, studies report how symptoms evolved in the observed populations during the initial phase of treatment. These findings contribute to the broader evidence landscape for short-term fluid volume changes.

What remains uncertain involves the long-term impact. Long-term outcomes are not extensively characterized by large-scale clinical trials comparing Furosemide specifically to a neutral control. Data show patterns related to hospitalizations over extended periods, but this evidence largely comes from observational settings, and the results apply only to the populations studied, often requiring careful interpretation due to complex health factors. Comparative evidence involving other loop diuretics over many years also remains mixed, and certainty remains low regarding differences in major long-term outcomes.


Evidence for Fluid Retention Associated with Kidney Diseases

Research exploring Furosemide use in conditions involving fluid retention due to kidney diseases was evaluated in studies focusing on high-dose regimens and in patients with significantly reduced kidney function. Research has explored its role in fluid overload in various clinical contexts. Primary outcomes monitored included total urine output, salt excretion, and changes measured in the patient's fluid status.

In this population, where symptoms may vary in intensity, studies reported measurements of significant diuresis and salt excretion, even in individuals with advanced kidney impairment. Research highlights changes measured during the study period, indicating that patterns of diuretic response were observed in some studies in patients who had an incomplete response to other standard diuretics. Findings help contextualize the evidence describing how symptoms are measured in challenging fluid overload scenarios.

Key limitations noted in the research include that follow-up durations were often limited, with most studies focusing on acute or short-term responses (hours to weeks) rather than tracking long-term cardiovascular or kidney health outcomes. Comparative evidence against other newer agents for long-term outcomes is lacking, and there is limited information for long-term outcomes regarding the medicine's impact on the rate of kidney disease progression.

Key Studies & References

  1. Furosemide (Lasix) Drug Label Information – NIH DailyMed

Frequently Asked Questions (FAQ)

Common questions about Lasex (FAQ)

Q: What is the main reason Lasex is prescribed, aside from just swelling?

In addition to fluid accumulation (edema) related to congestive heart failure, liver, or kidney disease, official prescribing information indicates that Lasex is also indicated for the treatment of hypertension (high blood pressure). The drug’s main function is described as helping the body excrete excess water and salt.


Q: How quickly does Lasex start working after I take the tablet?

According to the official product information, the onset of increased urination following oral administration (taking the tablet) is typically observed within 1 hour. This timing is a characteristic described in the drug’s pharmacological information.


Q: How long does the increased need to urinate last after taking a dose?

Official pharmacological data indicates that the duration of the major diuretic effect following a standard oral dose is typically 6 to 8 hours. The period of increased urination is generally expected to be most pronounced during this timeframe.


Q: What are the most common side effects people report online?

Official documents list the most frequently reported adverse reactions as those related to fluid and electrolyte changes. These commonly include effects such as dizziness, headache, dry mouth, thirst, and gastrointestinal discomfort. The frequency of these effects is documented in regulatory safety information.


Q: Why is Lasex sometimes used for people with kidney or liver problems?

It is indicated for the treatment of fluid retention (edema) specifically associated with conditions like liver cirrhosis and various forms of renal disease, including the nephrotic syndrome. Its pharmacological action is intended to address excess fluid buildup that is often a symptom of these organ impairments.


Q: Does taking Lasex mean I need to drink a specific amount of water or fluids?

Official information emphasizes that the medicine can cause significant loss of water and electrolytes, leading to a risk of excessive fluid loss. Because of this, patients may experience symptoms like thirst or dry mouth. Monitoring of fluid status by a healthcare professional is required during treatment.


Q: Can Lasex affect my blood sugar levels or is that a concern?

Increases in blood glucose (sugar) levels and alterations in glucose tolerance tests have been observed. The product label states that patients with diabetes should be informed that the medicine may increase their blood glucose levels.


Q: What does it mean that Lasex is a 'potent' diuretic?

Regulatory documents designate Lasex as a potent diuretic because it has the capacity to lead to a profound and rapid loss of water and electrolytes from the body. This characteristic underscores the requirement for medical supervision.


Q: Does Lasex interact with alcohol, and what kind of effect does it have?

Official warnings note that the adverse effect of orthostatic hypotension can occur while taking this medicine. This effect, which involves dizziness or lightheadedness when changing position, is described in the label as potentially enhanced by alcohol.


Q: Why do some people take Lasex only a few times a week instead of daily?

The dosage and schedule is determined based on the patient’s individual needs. For certain chronic conditions, an intermittent schedule may be prescribed to achieve the therapeutic goal.


Q: If I am taking Lasex for blood pressure, how will I know it is working?

The medication is indicated to treat high blood pressure, which is a condition that requires professional monitoring. Monitoring the patient's blood pressure is the primary method used to evaluate the effect of the medicine for this indication.


Q: Does the use of Lasex affect cholesterol or triglyceride blood test results?

Regulatory documents report that an increase in cholesterol and triglyceride serum levels has been observed as a possible adverse cardiovascular reaction.


Q: Can Lasex interact with other heart medications, such as digoxin?

Official documents warn that co-treatment with Digitalis (which includes digoxin) may increase the risk of adverse effects. The risk of heart-related effects due to low potassium (hypokalemia) may be exaggerated when these medicines are taken together.


Q: If I have gout, is Lasex still appropriate to take?

The regulatory label describes that use should be approached with caution in patients with gout. Official warnings note the medication can cause asymptomatic hyperuricemia (increased uric acid levels), which has been known to rarely trigger a gout flare.


Q: What is the difference in action between Lasex (loop diuretic) and a thiazide diuretic?

Lasex is classified as a Loop Diuretic and works by acting directly on the Loop of Henle in the kidney, which is the primary site of its action. Its mechanism is also described as being independent of the effects of aldosterone, a characteristic that differentiates it from how some other classes of diuretics work.


Q: Why would a doctor combine Lasex with a potassium-sparing diuretic?

Lasex can cause low potassium (hypokalemia) as a side effect. Combining it with a potassium-sparing diuretic is a method employed to address the risk of this electrolyte imbalance by counteracting the potassium loss caused by Lasex.


Q: What should I do if I experience severe vomiting or diarrhea while on Lasex?

Severe vomiting or diarrhea can cause significant fluid and electrolyte loss. If this occurs, monitoring of serum and urine electrolyte determinations is required by a healthcare professional. Any abnormalities may require correction or the drug may be temporarily withdrawn.


Q: Does Lasex affect how other medicines are cleared from the body?

Yes, the official label notes that Furosemide is known to reduce the renal clearance (the rate at which a substance is removed by the kidneys) of the drug Lithium. This effect can lead to increased serum levels of Lithium, resulting in a risk of toxicity.


Q: How does a doctor determine the right frequency or dosage for Lasex?

The dose and dose schedule is determined based on the patient's individual needs. This process requires careful medical supervision due to the drug's effect on fluid and electrolyte balance.


Q: Do studies show that Lasex is safe for breastfeeding mothers?

Official documents note that Furosemide is passed to the infant during breastfeeding. Some regulatory bodies state that breastfeeding is contraindicated if the medicine is taken, as it may suppress lactation.


Q: Can Lasex cause an increase in uric acid levels?

Yes, official warnings confirm that asymptomatic hyperuricemia (increased uric acid levels without symptoms) can occur. This condition is mentioned in the label as potentially leading to a flare-up of gout in rare instances.


Q: How do medical professionals monitor for ototoxicity (hearing damage) when using high doses of Lasex?

To help minimize the risk of ototoxicity (hearing damage), especially when high doses are needed, official guidance describes that the medicine is administered via a controlled intravenous infusion. The recommended infusion rate generally must not exceed 4 mg per minute in adults.


Q: Is there any research on Lasex being used to treat pulmonary edema?

Yes, regulatory labeling describes a specific initial dose and administration method for the treatment of Acute Pulmonary Edema (fluid in the lungs). This use is a part of the established indications for the medication.


Q: What is the appearance (color, shape) of the Lasex tablet?

Furosemide tablets for oral administration are generally described as white tablets in the official product information. They are available in various shapes, such as round or oval, depending on the strength and the specific manufacturer.

How should Lasex be stored and disposed of?

How to Store and Dispose of Lasix (Furosemide)

Lasix (Furosemide) must be stored and handled according to specific conditions mandated by regulatory labeling to maintain its stability.

Storage Requirements

Condition Requirement (Official Labeling)
Temperature Store at Controlled Room Temperature (20 C to 25 C), with excursions allowed up to 30 C.
Protection Must be protected from light. The injection solution must not be frozen.
Container Tablets should be stored in a tightly closed container; injection solution must be visually inspected before use.
Child Safety Keep stored out of the sight and reach of children.

Disposal

Any unused medicine or waste material must be disposed of in accordance with local requirements for pharmaceutical waste. Unused portions of single-dose injection vials must be discarded. Furosemide is not included on the official list of medicines recommended for disposal by flushing.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Lasex found in:

A-Z Index: